Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Summary

The purpose of this study is to evaluate the safety and efficacy of fixed combination of lercanidipine (10 mg or 20 mg) and valsartan (80 mg or 160 mg), lercanidipine and valsartan alone in reducing blood pressure. The study will investigate the dose response relationship for the combinations and monotherapies.

Timeline

Start

2009-12

Primary completion

2010-05

Completion

2010-07

Drugs

Indications